1
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
323,358
$15.0m14.86%
14.86%
Reduced Shares held: Q3 2024 1.4m, Q4 2024 1.4m, Q1 2025 685.2k, Q2 2025 323.4k
-361.8k
-361,834
-52.8%
2
KLA CORP
COM NEW
KLAC
KLAC
15,848
$14.2m14.10%
14.10%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 15.8k
3
CORCEPT THERAPEUTICS INC
COM
CORT
CORT
67,200
$4.9m4.90%
4.90%
Added Shares held: Q3 2024 148.0k, Q4 2024 148.0k, Q1 2025 66.0k, Q2 2025 67.2k
+1.2k
+1,200
1.8%
4
OVINTIV INC
COM
OVV
OVV
107,500
$4.1m4.06%
4.06%
Added Shares held: Q3 2024 104.4k, Q4 2024 104.4k, Q1 2025 52.2k, Q2 2025 107.5k
+55.3k
+55,300
105.9%
5
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
187,800
$4.1m4.02%
4.02%
Reduced Shares held: Q3 2024 800.8k, Q4 2024 676.8k, Q1 2025 263.4k, Q2 2025 187.8k
-75.6k
-75,600
-28.7%
6
NEUROCRINE BIOSCIENCES INC
COM
NBIX
NBIX
30,940
$3.9m3.86%
3.86%
Added Shares held: Q3 2024 60.5k, Q4 2024 60.5k, Q1 2025 30.2k, Q2 2025 30.9k
+700
+700
2.3%
7
PHREESIA INC
COM
PHR
PHR
114,700
$3.3m3.24%
3.24%
Unchanged Shares held: Q3 2024 229.4k, Q4 2024 229.4k, Q1 2025 114.7k, Q2 2025 114.7k
8
PROTHENA CORP PLC
SHS
PRTA
PRTA
451,019
$2.7m2.72%
2.72%
Added Shares held: Q3 2024 419.1k, Q4 2024 609.1k, Q1 2025 333.0k, Q2 2025 451.0k
+118.0k
+118,045
35.5%
9
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
48,000
$2.7m2.63%
2.63%
Reduced Shares held: Q3 2024 96.0k, Q4 2024 96.0k, Q1 2025 48.0k, Q2 2025 48.0k
-2
-2
0.0%
10
STOKE THERAPEUTICS INC
COM
STOK
STOK
210,000
$2.4m2.37%
2.37%
Reduced Shares held: Q3 2024 420.0k, Q4 2024 420.0k, Q1 2025 210.0k, Q2 2025 210.0k
-5
-5
0.0%
11
ELUTIA INC
CL A COM
ELUT
ELUT
1,159,059
$2.3m2.28%
2.28%
Reduced Shares held: Q3 2024 2.6m, Q4 2024 2.5m, Q1 2025 1.2m, Q2 2025 1.2m
-28.7k
-28,676
-2.4%
12
CASTLE BIOSCIENCES INC
COM
CSTL
CSTL
110,600
$2.3m2.24%
2.24%
Added Shares held: Q3 2024 116.0k, Q4 2024 156.0k, Q1 2025 88.4k, Q2 2025 110.6k
+22.2k
+22,196
25.1%
13
QUIDEL CORP
COM
QDEL
QDEL
72,548
$2.1m2.08%
2.08%
Added Shares held: Q3 2024 135.2k, Q4 2024 135.2k, Q1 2025 67.6k, Q2 2025 72.5k
+4.9k
+4,929
7.3%
14
EQT CORP
COM
EQT
EQT
34,619
$2.0m2.01%
2.01%
Unchanged Shares held: Q3 2024 69.2k, Q4 2024 69.2k, Q1 2025 34.6k, Q2 2025 34.6k
15
HARROW INC
COM
HROW
HROW
60,000
$1.8m1.82%
1.82%
Reduced Shares held: Q3 2024 145.8k, Q4 2024 145.8k, Q1 2025 72.9k, Q2 2025 60.0k
-12.9k
-12,910
-17.7%
16
NOVOCURE LTD
ORD SHS
NVCR
NVCR
101,000
$1.8m1.79%
1.79%
Added Shares held: Q3 2024 40.0k, Q4 2024 62.0k, Q1 2025 31.0k, Q2 2025 101.0k
+70.0k
+70,000
225.8%
17
AXOGEN INC
COM
AXGN
AXGN
161,000
$1.7m1.73%
1.73%
Unchanged Shares held: Q3 2024 394.0k, Q4 2024 394.0k, Q1 2025 161.0k, Q2 2025 161.0k
18
BIODESIX INC
COM
COM
5,736,113
$1.6m1.61%
1.61%
Unchanged Shares held: Q3 2024 11.2m, Q4 2024 11.3m, Q1 2025 5.7m, Q2 2025 5.7m
19
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
103,000
$1.5m1.51%
1.51%
Reduced Shares held: Q3 2024 296.0k, Q4 2024 296.0k, Q1 2025 138.0k, Q2 2025 103.0k
-35.0k
-35,000
-25.4%
20
FOGHORN THERAPEUTICS INC
COM
FHTX
FHTX
310,930
$1.5m1.45%
1.45%
Unchanged Shares held: Q3 2024 641.9k, Q4 2024 621.9k, Q1 2025 310.9k, Q2 2025 310.9k
21
ALKERMES PLC
SHS
ALKS
ALKS
50,000
$1.4m1.42%
1.42%
Unchanged Shares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 50.0k, Q2 2025 50.0k
22
MASIMO CORP
COM
MASI
MASI
8,280
$1.4m1.38%
1.38%
Reduced Shares held: Q3 2024 30.6k, Q4 2024 30.6k, Q1 2025 11.3k, Q2 2025 8.3k
-3.0k
-3,000
-26.6%
23
UNIQURE NV
SHS
QURE
QURE
98,697
$1.4m1.37%
1.37%
Added Shares held: Q3 2024 40.0k, Q4 2024 40.0k, Q1 2025 88.7k, Q2 2025 98.7k
+10.0k
+10,000
11.3%
24
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
4,250
$1.2m1.21%
1.21%
Reduced Shares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 7.5k, Q2 2025 4.2k
-3.2k
-3,250
-43.3%
25
DOCGO INC
COM
DCGO
DCGO
764,062
$1.2m1.19%
1.19%
Reduced Shares held: Q3 2024 1.0m, Q4 2024 1.5m, Q1 2025 864.1k, Q2 2025 764.1k
-100.0k
-100,000
-11.6%
26
TREACE MED CONCEPTS INC
COM
TMCI
TMCI
176,947
$1.0m1.03%
1.03%
Added Shares held: Q3 2024 136.7k, Q4 2024 322.7k, Q1 2025 164.9k, Q2 2025 176.9k
+12.0k
+12,000
7.3%
27
SOLID BIOSCIENCES INC
COM NEW
SLDB
SLDB
178,768
$870.6k0.86%
0.86%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 128.8k, Q2 2025 178.8k
+50.0k
+50,000
38.8%
28
KINIKSA PHARMACEUTICALS LTD
COM CL A
COM CL A
30,000
$830.1k0.82%
0.82%
Reduced Shares held: Q3 2024 60.0k, Q4 2024 60.0k, Q1 2025 30.0k, Q2 2025 30.0k
-6
-6
-0.0%
29
FREEPORT-MCMORAN INC
CL B
FCX
FCX
18,033
$781.7k0.78%
0.78%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 18.0k
30
KALVISTA PHARMACEUTICALS INC
COM
KALV
KALV
67,000
$757.4k0.75%
0.75%
Reduced Shares held: Q3 2024 164.0k, Q4 2024 134.0k, Q1 2025 67.0k, Q2 2025 67.0k
-2
-2
0.0%
31
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
36,000
$746.6k0.74%
0.74%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 36.0k
32
APOGEE THERAPEUTICS INC
COM
COM
16,000
$694.9k0.69%
0.69%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 8.0k, Q2 2025 16.0k
+8.0k
+8,000
100.0%
33
OUTSET MED INC
COM
OM
OM
34,584
$664.4k0.66%
0.66%
Added Shares held: Q3 2024 20.0k, Q4 2024 737.5k, Q1 2025 24.6k, Q2 2025 34.6k
+10.0k
+10,000
40.7%
34
XENON PHARMACEUTICALS INC
COM
XENE
XENE
21,000
$657.3k0.65%
0.65%
Unchanged Shares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 21.0k, Q2 2025 21.0k
35
ULTRAGENYX PHARMACEUTICAL IN
COM
RARE
RARE
18,000
$654.5k0.65%
0.65%
Added Shares held: Q3 2024 0, Q4 2024 32.0k, Q1 2025 16.0k, Q2 2025 18.0k
+2.0k
+2,000
12.5%
36
AXSOME THERAPEUTICS INC
COM
AXSM
AXSM
6,000
$626.3k0.62%
0.62%
Unchanged Shares held: Q3 2024 8.0k, Q4 2024 8.0k, Q1 2025 6.0k, Q2 2025 6.0k
37
OLEMA PHARMACEUTICALS INC
COM
OLMA
OLMA
134,000
$570.8k0.57%
0.57%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 134.0k
38
SCHOLAR ROCK HLDG CORP
COM
SRRK
SRRK
16,000
$566.7k0.56%
0.56%
Unchanged Shares held: Q3 2024 0, Q4 2024 16.0k, Q1 2025 16.0k, Q2 2025 16.0k
39
INTELLIA THERAPEUTICS INC
COM
NTLA
NTLA
60,000
$562.8k0.56%
0.56%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.0k
40
ORTHOPEDIATRICS CORP
COM
KIDS
KIDS
26,000
$558.5k0.55%
0.55%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 20.0k, Q2 2025 26.0k
+6.0k
+6,000
30.0%
41
IMMUNOME INC
COM
IMNM
IMNM
60,000
$558.0k0.55%
0.55%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.0k
42
XENCOR INC
COM
XNCR
XNCR
70,000
$550.2k0.55%
0.55%
Added Shares held: Q3 2024 24.6k, Q4 2024 52.0k, Q1 2025 26.0k, Q2 2025 70.0k
+44.0k
+44,000
169.2%
43
HALOZYME THERAPEUTICS INC
COM
HALO
HALO
10,000
$520.2k0.52%
0.52%
Unchanged Shares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 10.0k, Q2 2025 10.0k
44
PACIFIC BIOSCIENCES CALIF IN
COM
PACB
PACB
400,000
$496.0k0.49%
0.49%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 400.0k
45
INHIBRX BIOSCIENCES INC
COM
INBX
INBX
32,110
$458.2k0.46%
0.46%
Unchanged Shares held: Q3 2024 64.2k, Q4 2024 64.2k, Q1 2025 32.1k, Q2 2025 32.1k
46
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
MLTX
MLTX
8,000
$377.6k0.37%
0.37%
Unchanged Shares held: Q3 2024 0, Q4 2024 8.0k, Q1 2025 8.0k, Q2 2025 8.0k
47
ALPHATEC HLDGS INC
COM NEW
ATEC
ATEC
33,000
$366.3k0.36%
0.36%
Unchanged Shares held: Q3 2024 396.0k, Q4 2024 116.0k, Q1 2025 33.0k, Q2 2025 33.0k
48
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
40,000
$358.4k0.36%
0.36%
Unchanged Shares held: Q3 2024 80.0k, Q4 2024 80.0k, Q1 2025 40.0k, Q2 2025 40.0k
49
BLUEPRINT MEDICINES CORP
COM
BPMC
BPMC
2,700
$346.1k0.34%
0.34%
Unchanged Shares held: Q3 2024 5.4k, Q4 2024 5.4k, Q1 2025 2.7k, Q2 2025 2.7k
50
CYTOKINETICS INC
COM NEW
CYTK
CYTK
10,000
$330.4k0.33%
0.33%
Unchanged Shares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 10.0k, Q2 2025 10.0k
51
CANDEL THERAPEUTICS INC
COM
CADL
CADL
60,000
$303.6k0.30%
0.30%
Unchanged Shares held: Q3 2024 0, Q4 2024 120.0k, Q1 2025 60.0k, Q2 2025 60.0k
52
TELA BIO INC
COM
TELA
TELA
155,000
$300.7k0.30%
0.30%
Unchanged Shares held: Q3 2024 0, Q4 2024 250.0k, Q1 2025 155.0k, Q2 2025 155.0k
53
COGENT BIOSCIENCES INC
COM
COGT
COGT
40,000
$287.2k0.29%
0.29%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 40.0k
54
WAVE LIFE SCIENCES LTD
SHS
96663EUR
96663EUR
40,300
$261.9k0.26%
0.26%
Unchanged Shares held: Q3 2024 80.0k, Q4 2024 80.0k, Q1 2025 40.3k, Q2 2025 40.3k
55
10X GENOMICS INC
CL A COM
TXG
TXG
22,000
$254.8k0.25%
0.25%
Reduced Shares held: Q3 2024 60.0k, Q4 2024 100.0k, Q1 2025 50.0k, Q2 2025 22.0k
-28.0k
-28,000
-56.0%
56
APELLIS PHARMACEUTICALS INC
COM
APLS
APLS
14,000
$242.3k0.24%
0.24%
Unchanged Shares held: Q3 2024 28.0k, Q4 2024 28.0k, Q1 2025 14.0k, Q2 2025 14.0k
57
PHATHOM PHARMACEUTICALS INC
COM
PHAT
PHAT
25,000
$239.8k0.24%
0.24%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 25.0k
58
BRIDGEBIO PHARMA INC
COM
BBIO
BBIO
5,000
$215.9k0.21%
0.21%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.0k
59
NEUROPACE INC
COM
NPCE
NPCE
16,442
$183.2k0.18%
0.18%
Unchanged Shares held: Q3 2024 0, Q4 2024 20.0k, Q1 2025 16.4k, Q2 2025 16.4k
60
GOSSAMER BIO INC
COM
GOSS
GOSS
138,176
$170.0k0.17%
0.17%
Unchanged Shares held: Q3 2024 276.4k, Q4 2024 276.4k, Q1 2025 138.2k, Q2 2025 138.2k
61
AMICUS THERAPEUTICS INC
COM
FOLD
FOLD
28,000
$160.4k0.16%
0.16%
Unchanged Shares held: Q3 2024 56.0k, Q4 2024 56.0k, Q1 2025 28.0k, Q2 2025 28.0k
62
ZENAS BIOPHARMA INC
COM
ZBIO
ZBIO
16,500
$159.9k0.16%
0.16%
Unchanged Shares held: Q3 2024 0, Q4 2024 33.0k, Q1 2025 16.5k, Q2 2025 16.5k
63
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
20,000
$150.6k0.15%
0.15%
Unchanged Shares held: Q3 2024 40.0k, Q4 2024 40.0k, Q1 2025 20.0k, Q2 2025 20.0k
64
KARYOPHARM THERAPEUTICS INC
COM
COM
27,985
$120.6k0.12%
0.12%
Unchanged Shares held: Q3 2024 939.7k, Q4 2024 839.7k, Q1 2025 28.0k, Q2 2025 28.0k
65
APPLIED THERAPEUTICS INC
COM
APLT
APLT
280,000
$87.1k0.09%
0.09%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 280.0k
66
VENTYX BIOSCIENCES INC
COM
VTYX
VTYX
28,800
$61.6k0.06%
0.06%
Unchanged Shares held: Q3 2024 57.6k, Q4 2024 57.6k, Q1 2025 28.8k, Q2 2025 28.8k
67
INFLARX NV
COM
IFRX
IFRX
50,000
$39.5k0.04%
0.04%
Unchanged Shares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 50.0k, Q2 2025 50.0k
68
APTEVO THERAPEUTICS INC
COM NEW
COM NEW
10,000
$30.5k0.03%
0.03%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 10.0k
69
ALUMIS INC
COM
ALMS
ALMS
10,000
$30.0k0.03%
0.03%
Unchanged Shares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 10.0k, Q2 2025 10.0k
70
ZENTALIS PHARMACEUTICALS INC
COM
ZNTL
ZNTL
17,000
$19.7k0.02%
0.02%
Unchanged Shares held: Q3 2024 32.0k, Q4 2024 34.0k, Q1 2025 17.0k, Q2 2025 17.0k
71
ACCELERATE DIAGNOSTICS INC
COM
COM
325,239
$2.1k0.00%
0.00%
Unchanged Shares held: Q3 2024 650.5k, Q4 2024 650.5k, Q1 2025 325.2k, Q2 2025 325.2k